Global Immune Checkpoint Inhibitors Market Insights and Forecast to 2026

Global Immune Checkpoint Inhibitors Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Immune Checkpoint Inhibitors Product Introduction
1.2 Market Segments
1.3 Key Immune Checkpoint Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immune Checkpoint Inhibitors Market Size Growth Rate by Type
1.4.2 PD-1/PD-L1
1.4.3 CTLA-4
1.5 Market by Application
1.5.1 Global Immune Checkpoint Inhibitors Market Size Growth Rate by Application
1.5.2 Lung Cancer
1.5.3 Colorectal Cancer
1.5.4 Breast Cancer
1.5.5 Prostate Cancer
1.5.6 Melanoma
1.5.7 Blood Cancer
1.5.8 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immune Checkpoint Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global Immune Checkpoint Inhibitors Revenue 2015-2026
2.1.2 Global Immune Checkpoint Inhibitors Sales 2015-2026
2.2 Global Immune Checkpoint Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Immune Checkpoint Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Immune Checkpoint Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Immune Checkpoint Inhibitors Competitor Landscape by Players
3.1 Immune Checkpoint Inhibitors Sales by Manufacturers
3.1.1 Immune Checkpoint Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Immune Checkpoint Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Immune Checkpoint Inhibitors Revenue by Manufacturers
3.2.1 Immune Checkpoint Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Immune Checkpoint Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immune Checkpoint Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immune Checkpoint Inhibitors Revenue in 2019
3.2.5 Global Immune Checkpoint Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Immune Checkpoint Inhibitors Price by Manufacturers
3.4 Immune Checkpoint Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Immune Checkpoint Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immune Checkpoint Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Immune Checkpoint Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immune Checkpoint Inhibitors Market Size by Type (2015-2020)
4.1.1 Global Immune Checkpoint Inhibitors Sales by Type (2015-2020)
4.1.2 Global Immune Checkpoint Inhibitors Revenue by Type (2015-2020)
4.1.3 Immune Checkpoint Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immune Checkpoint Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global Immune Checkpoint Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Immune Checkpoint Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Immune Checkpoint Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immune Checkpoint Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immune Checkpoint Inhibitors Market Size by Application (2015-2020)
5.1.1 Global Immune Checkpoint Inhibitors Sales by Application (2015-2020)
5.1.2 Global Immune Checkpoint Inhibitors Revenue by Application (2015-2020)
5.1.3 Immune Checkpoint Inhibitors Price by Application (2015-2020)
5.2 Immune Checkpoint Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global Immune Checkpoint Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Immune Checkpoint Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Immune Checkpoint Inhibitors Price Forecast by Application (2021-2026)
6 North America
6.1 North America Immune Checkpoint Inhibitors by Country
6.1.1 North America Immune Checkpoint Inhibitors Sales by Country
6.1.2 North America Immune Checkpoint Inhibitors Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Immune Checkpoint Inhibitors Market Facts & Figures by Type
6.3 North America Immune Checkpoint Inhibitors Market Facts & Figures by Application
7 Europe
7.1 Europe Immune Checkpoint Inhibitors by Country
7.1.1 Europe Immune Checkpoint Inhibitors Sales by Country
7.1.2 Europe Immune Checkpoint Inhibitors Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immune Checkpoint Inhibitors Market Facts & Figures by Type
7.3 Europe Immune Checkpoint Inhibitors Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Immune Checkpoint Inhibitors by Region
8.1.1 Asia Pacific Immune Checkpoint Inhibitors Sales by Region
8.1.2 Asia Pacific Immune Checkpoint Inhibitors Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Immune Checkpoint Inhibitors Market Facts & Figures by Type
8.3 Asia Pacific Immune Checkpoint Inhibitors Market Facts & Figures by Application
9 Latin America
9.1 Latin America Immune Checkpoint Inhibitors by Country
9.1.1 Latin America Immune Checkpoint Inhibitors Sales by Country
9.1.2 Latin America Immune Checkpoint Inhibitors Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Immune Checkpoint Inhibitors Market Facts & Figures by Type
9.3 Central & South America Immune Checkpoint Inhibitors Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Immune Checkpoint Inhibitors by Country
10.1.1 Middle East and Africa Immune Checkpoint Inhibitors Sales by Country
10.1.2 Middle East and Africa Immune Checkpoint Inhibitors Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Immune Checkpoint Inhibitors Market Facts & Figures by Type
10.3 Middle East and Africa Immune Checkpoint Inhibitors Market Facts & Figures by Application
11 Company Profiles
11.1 Bristol Myer Squibb
11.1.1 Bristol Myer Squibb Corporation Information
11.1.2 Bristol Myer Squibb Description and Business Overview
11.1.3 Bristol Myer Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol Myer Squibb Immune Checkpoint Inhibitors Products Offered
11.1.5 Bristol Myer Squibb Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Immune Checkpoint Inhibitors Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Merck & Co.
11.3.1 Merck & Co. Corporation Information
11.3.2 Merck & Co. Description and Business Overview
11.3.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck & Co. Immune Checkpoint Inhibitors Products Offered
11.3.5 Merck & Co. Related Developments
11.4 Roche / Genentech
11.4.1 Roche / Genentech Corporation Information
11.4.2 Roche / Genentech Description and Business Overview
11.4.3 Roche / Genentech Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Roche / Genentech Immune Checkpoint Inhibitors Products Offered
11.4.5 Roche / Genentech Related Developments
11.5 Incyte Corporation
11.5.1 Incyte Corporation Corporation Information
11.5.2 Incyte Corporation Description and Business Overview
11.5.3 Incyte Corporation Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Incyte Corporation Immune Checkpoint Inhibitors Products Offered
11.5.5 Incyte Corporation Related Developments
11.6 NewLink Genetics
11.6.1 NewLink Genetics Corporation Information
11.6.2 NewLink Genetics Description and Business Overview
11.6.3 NewLink Genetics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 NewLink Genetics Immune Checkpoint Inhibitors Products Offered
11.6.5 NewLink Genetics Related Developments
11.7 ArGEN-X
11.7.1 ArGEN-X Corporation Information
11.7.2 ArGEN-X Description and Business Overview
11.7.3 ArGEN-X Sales, Revenue and Gross Margin (2015-2020)
11.7.4 ArGEN-X Immune Checkpoint Inhibitors Products Offered
11.7.5 ArGEN-X Related Developments
11.8 Seattle Genetics
11.8.1 Seattle Genetics Corporation Information
11.8.2 Seattle Genetics Description and Business Overview
11.8.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Seattle Genetics Immune Checkpoint Inhibitors Products Offered
11.8.5 Seattle Genetics Related Developments
11.9 Pfizer
11.9.1 Pfizer Corporation Information
11.9.2 Pfizer Description and Business Overview
11.9.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pfizer Immune Checkpoint Inhibitors Products Offered
11.9.5 Pfizer Related Developments
11.10 MacroGenics
11.10.1 MacroGenics Corporation Information
11.10.2 MacroGenics Description and Business Overview
11.10.3 MacroGenics Sales, Revenue and Gross Margin (2015-2020)
11.10.4 MacroGenics Immune Checkpoint Inhibitors Products Offered
11.10.5 MacroGenics Related Developments
11.1 Bristol Myer Squibb
11.1.1 Bristol Myer Squibb Corporation Information
11.1.2 Bristol Myer Squibb Description and Business Overview
11.1.3 Bristol Myer Squibb Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bristol Myer Squibb Immune Checkpoint Inhibitors Products Offered
11.1.5 Bristol Myer Squibb Related Developments
11.12 CureTech
11.12.1 CureTech Corporation Information
11.12.2 CureTech Description and Business Overview
11.12.3 CureTech Sales, Revenue and Gross Margin (2015-2020)
11.12.4 CureTech Products Offered
11.12.5 CureTech Related Developments
11.13 Immutep
11.13.1 Immutep Corporation Information
11.13.2 Immutep Description and Business Overview
11.13.3 Immutep Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Immutep Products Offered
11.13.5 Immutep Related Developments
11.14 Innate Pharma
11.14.1 Innate Pharma Corporation Information
11.14.2 Innate Pharma Description and Business Overview
11.14.3 Innate Pharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Innate Pharma Products Offered
11.14.5 Innate Pharma Related Developments
11.15 Sorrento Therapeutics
11.15.1 Sorrento Therapeutics Corporation Information
11.15.2 Sorrento Therapeutics Description and Business Overview
11.15.3 Sorrento Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sorrento Therapeutics Products Offered
11.15.5 Sorrento Therapeutics Related Developments
11.16 GlaxoSmithKline
11.16.1 GlaxoSmithKline Corporation Information
11.16.2 GlaxoSmithKline Description and Business Overview
11.16.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.16.4 GlaxoSmithKline Products Offered
11.16.5 GlaxoSmithKline Related Developments
11.17 GITR, Inc
11.17.1 GITR, Inc Corporation Information
11.17.2 GITR, Inc Description and Business Overview
11.17.3 GITR, Inc Sales, Revenue and Gross Margin (2015-2020)
11.17.4 GITR, Inc Products Offered
11.17.5 GITR, Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Immune Checkpoint Inhibitors Market Estimates and Projections by Region
12.1.1 Global Immune Checkpoint Inhibitors Sales Forecast by Regions 2021-2026
12.1.2 Global Immune Checkpoint Inhibitors Revenue Forecast by Regions 2021-2026
12.2 North America Immune Checkpoint Inhibitors Market Size Forecast (2021-2026)
12.2.1 North America: Immune Checkpoint Inhibitors Sales Forecast (2021-2026)
12.2.2 North America: Immune Checkpoint Inhibitors Revenue Forecast (2021-2026)
12.2.3 North America: Immune Checkpoint Inhibitors Market Size Forecast by Country (2021-2026)
12.3 Europe Immune Checkpoint Inhibitors Market Size Forecast (2021-2026)
12.3.1 Europe: Immune Checkpoint Inhibitors Sales Forecast (2021-2026)
12.3.2 Europe: Immune Checkpoint Inhibitors Revenue Forecast (2021-2026)
12.3.3 Europe: Immune Checkpoint Inhibitors Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Immune Checkpoint Inhibitors Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Immune Checkpoint Inhibitors Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Immune Checkpoint Inhibitors Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Immune Checkpoint Inhibitors Market Size Forecast by Region (2021-2026)
12.5 Latin America Immune Checkpoint Inhibitors Market Size Forecast (2021-2026)
12.5.1 Latin America: Immune Checkpoint Inhibitors Sales Forecast (2021-2026)
12.5.2 Latin America: Immune Checkpoint Inhibitors Revenue Forecast (2021-2026)
12.5.3 Latin America: Immune Checkpoint Inhibitors Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Immune Checkpoint Inhibitors Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Immune Checkpoint Inhibitors Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Immune Checkpoint Inhibitors Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Immune Checkpoint Inhibitors Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Immune Checkpoint Inhibitors Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immune Checkpoint Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Immune Checkpoint Inhibitors Market Segments
Table 2. Ranking of Global Top Immune Checkpoint Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Immune Checkpoint Inhibitors Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of PD-1/PD-L1
Table 5. Major Manufacturers of CTLA-4
Table 6. Global Immune Checkpoint Inhibitors Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Immune Checkpoint Inhibitors Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Immune Checkpoint Inhibitors Sales by Regions 2015-2020 (MT)
Table 9. Global Immune Checkpoint Inhibitors Sales Market Share by Regions (2015-2020)
Table 10. Global Immune Checkpoint Inhibitors Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Immune Checkpoint Inhibitors Sales by Manufacturers (2015-2020) (MT)
Table 12. Global Immune Checkpoint Inhibitors Sales Share by Manufacturers (2015-2020)
Table 13. Global Immune Checkpoint Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Immune Checkpoint Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Checkpoint Inhibitors as of 2019)
Table 15. Immune Checkpoint Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Immune Checkpoint Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Immune Checkpoint Inhibitors Price (2015-2020) (USD/Kg)
Table 18. Immune Checkpoint Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Immune Checkpoint Inhibitors Product Type
Table 20. Date of International Manufacturers Enter into Immune Checkpoint Inhibitors Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Immune Checkpoint Inhibitors Sales by Type (2015-2020) (MT)
Table 23. Global Immune Checkpoint Inhibitors Sales Share by Type (2015-2020)
Table 24. Global Immune Checkpoint Inhibitors Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Immune Checkpoint Inhibitors Revenue Share by Type (2015-2020)
Table 26. Immune Checkpoint Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 27. Global Immune Checkpoint Inhibitors Sales by Application (2015-2020) (MT)
Table 28. Global Immune Checkpoint Inhibitors Sales Share by Application (2015-2020)
Table 29. North America Immune Checkpoint Inhibitors Sales by Country (2015-2020) (MT)
Table 30. North America Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
Table 31. North America Immune Checkpoint Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
Table 33. North America Immune Checkpoint Inhibitors Sales by Type (2015-2020) (MT)
Table 34. North America Immune Checkpoint Inhibitors Sales Market Share by Type (2015-2020)
Table 35. North America Immune Checkpoint Inhibitors Sales by Application (2015-2020) (MT)
Table 36. North America Immune Checkpoint Inhibitors Sales Market Share by Application (2015-2020)
Table 37. Europe Immune Checkpoint Inhibitors Sales by Country (2015-2020) (MT)
Table 38. Europe Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
Table 39. Europe Immune Checkpoint Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
Table 41. Europe Immune Checkpoint Inhibitors Sales by Type (2015-2020) (MT)
Table 42. Europe Immune Checkpoint Inhibitors Sales Market Share by Type (2015-2020)
Table 43. Europe Immune Checkpoint Inhibitors Sales by Application (2015-2020) (MT)
Table 44. Europe Immune Checkpoint Inhibitors Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Immune Checkpoint Inhibitors Sales by Region (2015-2020) (MT)
Table 46. Asia Pacific Immune Checkpoint Inhibitors Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Immune Checkpoint Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Immune Checkpoint Inhibitors Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Immune Checkpoint Inhibitors Sales by Type (2015-2020) (MT)
Table 50. Asia Pacific Immune Checkpoint Inhibitors Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Immune Checkpoint Inhibitors Sales by Application (2015-2020) (MT)
Table 52. Asia Pacific Immune Checkpoint Inhibitors Sales Market Share by Application (2015-2020)
Table 53. Latin America Immune Checkpoint Inhibitors Sales by Country (2015-2020) (MT)
Table 54. Latin America Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Immune Checkpoint Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
Table 57. Latin America Immune Checkpoint Inhibitors Sales by Type (2015-2020) (MT)
Table 58. Latin America Immune Checkpoint Inhibitors Sales Market Share by Type (2015-2020)
Table 59. Latin America Immune Checkpoint Inhibitors Sales by Application (2015-2020) (MT)
Table 60. Latin America Immune Checkpoint Inhibitors Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Immune Checkpoint Inhibitors Sales by Country (2015-2020) (MT)
Table 62. Middle East and Africa Immune Checkpoint Inhibitors Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Immune Checkpoint Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Immune Checkpoint Inhibitors Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Immune Checkpoint Inhibitors Sales by Type (2015-2020) (MT)
Table 66. Middle East and Africa Immune Checkpoint Inhibitors Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Immune Checkpoint Inhibitors Sales by Application (2015-2020) (MT)
Table 68. Middle East and Africa Immune Checkpoint Inhibitors Sales Market Share by Application (2015-2020)
Table 69. Bristol Myer Squibb Corporation Information
Table 70. Bristol Myer Squibb Description and Major Businesses
Table 71. Bristol Myer Squibb Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 72. Bristol Myer Squibb Product
Table 73. Bristol Myer Squibb Recent Development
Table 74. AstraZeneca Corporation Information
Table 75. AstraZeneca Description and Major Businesses
Table 76. AstraZeneca Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. AstraZeneca Product
Table 78. AstraZeneca Recent Development
Table 79. Merck & Co. Corporation Information
Table 80. Merck & Co. Description and Major Businesses
Table 81. Merck & Co. Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Merck & Co. Product
Table 83. Merck & Co. Recent Development
Table 84. Roche / Genentech Corporation Information
Table 85. Roche / Genentech Description and Major Businesses
Table 86. Roche / Genentech Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Roche / Genentech Product
Table 88. Roche / Genentech Recent Development
Table 89. Incyte Corporation Corporation Information
Table 90. Incyte Corporation Description and Major Businesses
Table 91. Incyte Corporation Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Incyte Corporation Product
Table 93. Incyte Corporation Recent Development
Table 94. NewLink Genetics Corporation Information
Table 95. NewLink Genetics Description and Major Businesses
Table 96. NewLink Genetics Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. NewLink Genetics Product
Table 98. NewLink Genetics Recent Development
Table 99. ArGEN-X Corporation Information
Table 100. ArGEN-X Description and Major Businesses
Table 101. ArGEN-X Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. ArGEN-X Product
Table 103. ArGEN-X Recent Development
Table 104. Seattle Genetics Corporation Information
Table 105. Seattle Genetics Description and Major Businesses
Table 106. Seattle Genetics Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Seattle Genetics Product
Table 108. Seattle Genetics Recent Development
Table 109. Pfizer Corporation Information
Table 110. Pfizer Description and Major Businesses
Table 111. Pfizer Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Pfizer Product
Table 113. Pfizer Recent Development
Table 114. MacroGenics Corporation Information
Table 115. MacroGenics Description and Major Businesses
Table 116. MacroGenics Immune Checkpoint Inhibitors Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. MacroGenics Product
Table 118. MacroGenics Recent Development
Table 119. Celldex Therapeutics Corporation Information
Table 120. Celldex Therapeutics Description and Major Businesses
Table 121. Celldex Therapeutics Immune Checkpoint Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Celldex Therapeutics Product
Table 123. Celldex Therapeutics Recent Development
Table 124. CureTech Corporation Information
Table 125. CureTech Description and Major Businesses
Table 126. CureTech Immune Checkpoint Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. CureTech Product
Table 128. CureTech Recent Development
Table 129. Immutep Corporation Information
Table 130. Immutep Description and Major Businesses
Table 131. Immutep Immune Checkpoint Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. Immutep Product
Table 133. Immutep Recent Development
Table 134. Innate Pharma Corporation Information
Table 135. Innate Pharma Description and Major Businesses
Table 136. Innate Pharma Immune Checkpoint Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 137. Innate Pharma Product
Table 138. Innate Pharma Recent Development
Table 139. Sorrento Therapeutics Corporation Information
Table 140. Sorrento Therapeutics Description and Major Businesses
Table 141. Sorrento Therapeutics Immune Checkpoint Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 142. Sorrento Therapeutics Product
Table 143. Sorrento Therapeutics Recent Development
Table 144. GlaxoSmithKline Corporation Information
Table 145. GlaxoSmithKline Description and Major Businesses
Table 146. GlaxoSmithKline Immune Checkpoint Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 147. GlaxoSmithKline Product
Table 148. GlaxoSmithKline Recent Development
Table 149. GITR, Inc Corporation Information
Table 150. GITR, Inc Description and Major Businesses
Table 151. GITR, Inc Immune Checkpoint Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 152. GITR, Inc Product
Table 153. GITR, Inc Recent Development
Table 154. Global Immune Checkpoint Inhibitors Sales Forecast by Regions (2021-2026) (MT)
Table 155. Global Immune Checkpoint Inhibitors Sales Market Share Forecast by Regions (2021-2026)
Table 156. Global Immune Checkpoint Inhibitors Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 157. Global Immune Checkpoint Inhibitors Revenue Market Share Forecast by Regions (2021-2026)
Table 158. North America: Immune Checkpoint Inhibitors Sales Forecast by Country (2021-2026) (MT)
Table 159. North America: Immune Checkpoint Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Europe: Immune Checkpoint Inhibitors Sales Forecast by Country (2021-2026) (MT)
Table 161. Europe: Immune Checkpoint Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Asia Pacific: Immune Checkpoint Inhibitors Sales Forecast by Region (2021-2026) (MT)
Table 163. Asia Pacific: Immune Checkpoint Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Latin America: Immune Checkpoint Inhibitors Sales Forecast by Country (2021-2026) (MT)
Table 165. Latin America: Immune Checkpoint Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Middle East and Africa: Immune Checkpoint Inhibitors Sales Forecast by Country (2021-2026) (MT)
Table 167. Middle East and Africa: Immune Checkpoint Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Market Risks
Table 171. Main Points Interviewed from Key Immune Checkpoint Inhibitors Players
Table 172. Immune Checkpoint Inhibitors Customers List
Table 173. Immune Checkpoint Inhibitors Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Checkpoint Inhibitors Product Picture
Figure 2. Global Immune Checkpoint Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. PD-1/PD-L1 Product Picture
Figure 4. CTLA-4 Product Picture
Figure 5. Global Immune Checkpoint Inhibitors Sales Market Share by Application in 2020 & 2026
Figure 6. Lung Cancer
Figure 7. Colorectal Cancer
Figure 8. Breast Cancer
Figure 9. Prostate Cancer
Figure 10. Melanoma
Figure 11. Blood Cancer
Figure 12. Other
Figure 13. Immune Checkpoint Inhibitors Report Years Considered
Figure 14. Global Immune Checkpoint Inhibitors Market Size 2015-2026 (US$ Million)
Figure 15. Global Immune Checkpoint Inhibitors Sales 2015-2026 (MT)
Figure 16. Global Immune Checkpoint Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Immune Checkpoint Inhibitors Sales Market Share by Region (2015-2020)
Figure 18. Global Immune Checkpoint Inhibitors Sales Market Share by Region in 2019
Figure 19. Global Immune Checkpoint Inhibitors Revenue Market Share by Region (2015-2020)
Figure 20. Global Immune Checkpoint Inhibitors Revenue Market Share by Region in 2019
Figure 21. Global Immune Checkpoint Inhibitors Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Immune Checkpoint Inhibitors Revenue in 2019
Figure 23. Immune Checkpoint Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Immune Checkpoint Inhibitors Sales Market Share by Type (2015-2020)
Figure 25. Global Immune Checkpoint Inhibitors Sales Market Share by Type in 2019
Figure 26. Global Immune Checkpoint Inhibitors Revenue Market Share by Type (2015-2020)
Figure 27. Global Immune Checkpoint Inhibitors Revenue Market Share by Type in 2019
Figure 28. Global Immune Checkpoint Inhibitors Market Share by Price Range (2015-2020)
Figure 29. Global Immune Checkpoint Inhibitors Sales Market Share by Application (2015-2020)
Figure 30. Global Immune Checkpoint Inhibitors Sales Market Share by Application in 2019
Figure 31. Global Immune Checkpoint Inhibitors Revenue Market Share by Application (2015-2020)
Figure 32. Global Immune Checkpoint Inhibitors Revenue Market Share by Application in 2019
Figure 33. North America Immune Checkpoint Inhibitors Sales Growth Rate 2015-2020 (MT)
Figure 34. North America Immune Checkpoint Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Immune Checkpoint Inhibitors Sales Market Share by Country in 2019
Figure 36. North America Immune Checkpoint Inhibitors Revenue Market Share by Country in 2019
Figure 37. U.S. Immune Checkpoint Inhibitors Sales Growth Rate (2015-2020) (MT)
Figure 38. U.S. Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Immune Checkpoint Inhibitors Sales Growth Rate (2015-2020) (MT)
Figure 40. Canada Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Immune Checkpoint Inhibitors Market Share by Type in 2019
Figure 42. North America Immune Checkpoint Inhibitors Market Share by Application in 2019
Figure 43. Europe Immune Checkpoint Inhibitors Sales Growth Rate 2015-2020 (MT)
Figure 44. Europe Immune Checkpoint Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Immune Checkpoint Inhibitors Sales Market Share by Country in 2019
Figure 46. Europe Immune Checkpoint Inhibitors Revenue Market Share by Country in 2019
Figure 47. Germany Immune Checkpoint Inhibitors Sales Growth Rate (2015-2020) (MT)
Figure 48. Germany Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Immune Checkpoint Inhibitors Sales Growth Rate (2015-2020) (MT)
Figure 50. France Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Immune Checkpoint Inhibitors Sales Growth Rate (2015-2020) (MT)
Figure 52. U.K. Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Immune Checkpoint Inhibitors Sales Growth Rate (2015-2020) (MT)
Figure 54. Italy Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Immune Checkpoint Inhibitors Sales Growth Rate (2015-2020) (MT)
Figure 56. Russia Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Immu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cytokine Inhibitor Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......

Global Microbial Growth Media Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......

Global Protein Biochip Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92

Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......

Global Isothermal Nucleic Acid Amplification Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103

Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......

Global Microfluidics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122

According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......

Global Cytokines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......

Global Western Blot Imagers Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......

Global Procalcitonin Antibody Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs